Kolumne, ORE

Original-Research: S Immo AG - von NuWays AG Einstufung von NuWays AG zu S Immo AG Unternehmen: S Immo AG ISIN: AT0000652250 Anlass der Studie: Update Empfehlung: BUY seit: 06.02.2024 Kursziel: 18.40 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: Analyst: Philipp Sennewald Delisting indications getting stronger; chg.

06.02.2024 - 09:02:32

Original-Research: S Immo AG (von NuWays AG): BUY


Original-Research: S Immo AG - von NuWays AG

Einstufung von NuWays AG zu S Immo AG

Unternehmen: S Immo AG
ISIN: AT0000652250

Anlass der Studie: Update
Empfehlung: BUY
seit: 06.02.2024
Kursziel: 18.40
Kursziel auf Sicht von: 12 Monaten
Letzte Ratingänderung: 
Analyst: Philipp Sennewald

Delisting indications getting stronger; chg. PT
 
On Friday, S IMMO announced that the company will part ways with board
member Herwig Teufelsdorfer with immediate effect. At the same time the
supervisory board decided to appoint Tomá Salajka to the board, who is
also member of the Board of Directors of CPI Property Group (CPI), S IMMOs
majority shareholder. This comes after the company already parted ways with
former board member Holger Schmidtmayr in June. Like Mr Teufelsdorfer, Mr
Schmidtmayer was replaced with a person closely associated with CPI: Radka
Döhring. After Ms Döhring acted as Finance Director at CPI from 2012-2014,
she was announced as member of the board at IMMOFINANZ just two months
after CPI gained voting rights majority at the company.
 
With this, Radovan Vitek, founder, and majority shareholder (90.3% of
voting rights) of CPI, is seemingly implementing full operating control
over S IMMO and IMMOFINANZ, after acquiring majority stakes (88.4% in SPI &
77% in IIA) in 2022. Mind you, S IMMO also has 4.44% treasury shares. The
cancellation of which would lift CPI above the 90% squeeze-out threshold.
Moreover, S IMMO is currently running the second consecutive quarterly
share buyback (0.25% of targeted 1% bought back in Q4), hence lowering the
number of shares CPI would have to acquire at a higher price in the event
of a squeeze out.
 
Although a delisting would be sensible at first glance, considering the
current dual listing on the Vienna Stock Exchange (S IMMO & IMMOFINANZ) as
well as facilitation with regards to related-party-transactions, the
following questions arise: When and why not so far? While the question of
when is difficult to answer, one possible answer to the question of why it
has not happened yet is that CPI would have to pay a significant premium to
the current share price given the NTA of EUR 25.16 as well as the EUR 19.50 per
share, which IMMOFINANZ paid to acquire a 50% S IMMO stake from CPI in Q4
'22. Given CPIs high leverage (>50% LTV) as well as the short attack by
hedgefond Muddy Waters it is hence uncertain if the company is currently
willing to pay an additional EUR 100m (eNuW) for the remaining S IMMO share.
 
Yet, this brings us to the crucial point: Despite best-in-class metrics,
the incipient recovery of the real estate market and the looming
squeeze-out possibility, shares are trading on an NTA-discount similar to
the peer group (-41% as of yesterday's close price), which we regard highly
unjustified. The stock hence remains a strong BUY with a new PT of EUR 18.40
based on NTA and DDM.

Die vollständige Analyse können Sie hier downloaden:
http://www.more-ir.de/d/28821.pdf
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.

Kontakt für Rückfragen
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.
Kontakt für Rückfragen
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------übermittelt durch die EQS Group AG.-------------------


Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. 
Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung
oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.

@ dpa.de

Weitere Meldungen

Original-Research: Nynomic AG (von Montega AG): Kaufen Original-Research: Nynomic AG - von Montega AG Einstufung von Montega AG zu Nynomic AG Unternehmen: Nynomic AG ISIN: DE000A0MSN11 Anlass der Studie: Update Empfehlung: Kaufen seit: 10.05.2024 Kursziel: 47,00 EUR (zuvor: 48,00 EUR) Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Miguel Lago Mascato Q1: Solider Jahresauftakt - Steigerung der ausgezeichneten H2/23-Performance & M&A-Newsflow erwartet Nynomic hat Mittwoch Q1-Zahlen veröffentlicht, die eine spürbare Steigerung ggü. (Boerse, 10.05.2024 - 16:16) weiterlesen...

Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH)... Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to MPH Health Care AG Company Name: MPH Health Care AG ISIN: DE000A289V03 Reason for the research: Vorläufige Ergebnisse 2023 Recommendation: Kaufen from: 10.05.2024 Target price: EUR81 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. (Boerse, 10.05.2024 - 12:41) weiterlesen...

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): ... Original-Research: Knaus Tabbert AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Knaus Tabbert AG Company Name: Knaus Tabbert AG ISIN: DE000A2YN504 Reason for the research: Dreimonatsbericht Recommendation: Kaufen from: 10.05.2024 Target price: EUR86 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. (Boerse, 10.05.2024 - 11:46) weiterlesen...

Original-Research: ZEAL Network SE (von NuWays AG): Kaufen Original-Research: ZEAL Network SE - from NuWays AG Classification of NuWays AG to ZEAL Network SE Company Name: ZEAL Network SE ISIN: DE000ZEAL241 Reason for the research: Recommendation: Kaufen from: 10.05.2024 Target price: EUR 53.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Henry Wendisch Staggering Q1 kicks off new growth phase; chg est. (Boerse, 10.05.2024 - 09:07) weiterlesen...

Original-Research: Nynomic AG (von NuWays AG): Kaufen Original-Research: Nynomic AG - from NuWays AG Classification of NuWays AG to Nynomic AG Company Name: Nynomic AG ISIN: DE000A0MSN11 Reason for the research: Update Recommendation: Kaufen from: 10.05.2024 Target price: EUR 52.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Christian Sandherr Solid start into FY24 despite challenging end markets Topic: Nynomic published a solid start into the year with order intake returning to growth for the first time since Q3 2022. (Boerse, 10.05.2024 - 09:06) weiterlesen...

Original-Research: R. STAHL AG (von NuWays AG): Kaufen. STAHL AG - from NuWays AG Classification of NuWays AG to R. Original-Research: R. (Boerse, 10.05.2024 - 09:02) weiterlesen...